Ardana Bioscience Limited
Records under this name other than patents Ardana Bioscience Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Ardana Bioscience Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,192,719 | Methods and kits to diagnose growth hormone deficiency by oral administration of EP 1572 or EP 1573 compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,098,305 | Sustained release of microcrystalline peptide suspensions Formerly held Term ended Term ended Apr 9, 2023 · From the USPTO record | Term ended | Term ended Apr 9, 2023 | From the USPTO record |
| US 8,415,300 | Sustained release of microcrystalline peptide suspensions Formerly held Term ended Ended no later than Feb 19, 2022 · From the USPTO record | Term ended | Ended no later than Feb 19, 2022 | From the USPTO record |
| US 9,388,216 | Methods of treating reproductive cancer Formerly held Lapsed on the fee record Ended Jul 12, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jul 12, 2020 | From the USPTO record |
| US 7,361,633 | Screening method and anti-tumor drug candidate obtained therefrom Formerly held Lapsed on the fee record Ended Apr 22, 2020 · From the USPTO record | Lapsed on the fee record | Ended Apr 22, 2020 | From the USPTO record |
| US 6,187,323 | Stable gel mixture in the form of a mixture of oleogel and aqueous gel, process for its preparation, pharmaceutical and cosmetic compositions comprising it, and use of the pharmaceutical compositions Formerly held Term ended Term ended Dec 3, 2018 · From the USPTO record | Term ended | Term ended Dec 3, 2018 | From the USPTO record |
| US 7,615,210 | Treatment of endometriosis Formerly held Lapsed on the fee record Ended Nov 10, 2013 · From the USPTO record | Lapsed on the fee record | Ended Nov 10, 2013 | From the USPTO record |
| US 6,124,263 | Treatment of tumors by administration of growth hormone releasing compounds and their antagonists Lapsed on the fee record Ended Sep 26, 2012 · From the USPTO record | Lapsed on the fee record | Ended Sep 26, 2012 | From the USPTO record |
| US 6,077,523 | Process to manufacture implants containing bioactive peptides Lapsed on the fee record Ended Jun 20, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jun 20, 2012 | From the USPTO record |
| US 6,025,471 | Diazaspiro, azepino and azabicyclo therapeutic peptides Lapsed on the fee record Ended Feb 15, 2012 · From the USPTO record | Lapsed on the fee record | Ended Feb 15, 2012 | From the USPTO record |